T. Hawkins

发表

Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study.

J. Burke, K. Kolibaba, I. Flinn, 2014, Blood.

First-Line Treatment of Patients With Indolent Non-Hodgkin Lymphoma or Mantle-Cell Lymphoma With Bendamustine Plus Rituximab Versus R-CHOP or R-CVP: Results of the BRIGHT 5-Year Follow-Up Study.

J. Burke, K. Kolibaba, I. Flinn, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Blood cell transplantation

C. Juttner, T. Hawkins, 1995, Current opinion in oncology.

Differences in Quality of Life Between Bendamustine-Rituximab and R-CHOP/R-CVP in Patients With Previously Untreated Advanced Indolent Non-Hodgkin Lymphoma or Mantle Cell Lymphoma.

J. Burke, K. Kolibaba, I. Flinn, 2016, Clinical lymphoma, myeloma & leukemia.

Early treatment of acute promyelocytic leukaemia is accurately guided by the PML protein localisation pattern: real-life experience from a tertiary New Zealand centre.

P. Browett, Taryn N. Green, M. Kalev-Zylinska, 2019, Pathology.

Mycobacterium-Avium-Intracellulare Complex Infection Following 2-Chlorodeoxyadenosine Therapy For Hairy

R. Broady, S. Roberts, T. Hawkins, 2000, Leukemia & lymphoma.

Hematopoietic stem cell transplantation in Australia in 1993.

K. Atkinson, T. Hawkins, K. Downs, 1995, Journal of hematotherapy.

Tacrolimus and mycophenolate mofetil after nonmyeloablative matched-sibling donor allogeneic stem-cell transplantations conditioned with fludarabine and low-dose total body irradiation.

E. Shpall, A. Baron, Y. Nieto, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Treatment outcomes of patients with acute promyelocytic leukaemia between 2000 and 2017, a retrospective, single centre experience.

P. Browett, Taryn N. Green, M. Kalev-Zylinska, 2020, Leukemia research.

Presentation of intravascular lymphomatosis as lumbosacral polyradiculopathy

M. Croxson, D. Hutchinson, T. Hawkins, 2000, Muscle & nerve.

Assessment of Maintenance Rituximab after First-Line Bendamustine-Rituximab in Patients with Follicular Lymphoma: An Analysis from the BRIGHT Trial

J. Burke, K. Kolibaba, I. Flinn, 2017 .

First-line treatment of iNHL or MCL patients with BR or R-CHOP/R-CVP: Results of the BRIGHT 5-year follow-up study.

J. Burke, K. Kolibaba, I. Flinn, 2017 .

FIRST‐LINE TREATMENT OF INHL OR MCL PATIENTS WITH BR OR R‐CHOP/R‐CVP: RESULTS OF THE BRIGHT 5‐YEAR FOLLOW‐UP STUDY

J. Burke, K. Kolibaba, I. Flinn, 2017 .

Haemopoietic stem cell transplantation in Australia, 1992-95: a report from the Australian Bone Marrow Transplant Recipient Registry.

K. Atkinson, I. Nivison-Smith, T. Hawkins, 1997, Australian and New Zealand journal of medicine.

Addition of the mammalian target of rapamycin inhibitor, everolimus, to consolidation therapy in acute myeloid leukemia: experience from the UK NCRI AML17 trial

R. Hills, N. Russell, L. Kjeldsen, 2018, Haematologica.

An incremental response to high-dose therapy in multiple myeloma.

C. Andary, P. Dyson, C. Rawling, 1996, Bone marrow transplantation.